Jen Cadigan
Accounting Advisory, Life Sciences Lead
As a Partner in our Boston Accounting Advisory practice, Jen is focused on building Biovell’s expertise and market presence in the biotechnology industry. She works collaboratively with clients at emerging growth companies, helping them prepare for strategic transactions (IPO, M&A etc.) and supports them in the post-transaction environment. Jen has extensive technical accounting experience and helps clients account for complex agreements and transactions, as well as significant experience helping public and venture-backed companies through times of change, including establishing and optimizing processes, training people, and selecting technology. Jen has led teams through IPO’s, carve-outs, and strategic FinOps projects (such as accelerating close timeline, establishing SOX controls, as well as system selection and integration).
Jen has over 15 years of experience leading assurance and advisory teams across various industries. Prior to joining Biovell, she was a Senior Manager at Ernst & Young (EY) where she provided assurance services to companies of all sizes across various industries, with a focus on biotechnology. At EY, Jen was responsible for leading audit teams through several IPO’s, spin offs and divestures. She has had extensive involvement with SEC reporting requirements, internal control reporting, and technical accounting and reporting matters.
Jen has both a B.S. and MSA in Accounting from Boston College. She is a CPA registered in Massachusetts.